Fine-tuning the metabolic rewiring and adaptation of translational machinery during an epithelial-mesenchymal transition in breast cancer cells

• Published in: Cancer & metabolism Vol. 8; no. 1; p. 8
• Main Authors: Fernández-Calero, Tamara, Davyt, Marcos, Perelmuter, Karen, Chalar, Cora, Bampi, Giovana, Persson, Helena, Tosar, Juan Pablo, Hafstað, Völundur, Naya, Hugo, Rovira, Carlos, Bollati-Fogolín, Mariela, Ehrlich, Ricardo, Flouriot, Gilles, Ignatova, Zoya, Marín, Mónica
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 19.07.2020; BioMed Central; BMC
• Subjects: Adaptation; Analysis; Binding sites; Breast cancer; Cancer and Oncology; Cancer metastasis; Cancer och onkologi; Cell adhesion & migration; Clinical Medicine; Development and progression; EMT; Enzymes; Gene expression; Genetic aspects; Genomes; Genomics; Genotype & phenotype; Glucose; Klinisk medicin; Life Sciences; Luminal to basal transition; Medical and Health Sciences; Medicin och hälsovetenskap; Metabolism; Metabolism adaptation; Metastasis; MicroRNAs; MKL1/actin signaling pathway; Motility; Muscle proteins; Ontology; Phenols; Phosphates; Physiological aspects; RNA; RNA sequencing; Stem cells; Transcription (Genetics); Translation machinery; Tumors; United States > US; Luminal to basal transition; MKL1/actin signaling pathway; Breast cancer; Translation machinery; Breast cancer stem cells; EMT; Ribosome profiling; Metabolism adaptation; MKL1; actin signaling pathway
• ISSN: 2049-3002; 2049-3002
• DOI: 10.1186/s40170-020-00216-7

During breast cancer progression, the epithelial to mesenchymal transition has been associated with metastasis and endocrine therapy resistance; however, the underlying mechanisms remain elusive. To gain insight into this process, we studied the transition undergone by MCF7-derived cells, which is driven by the constitutive nuclear expression of a MKL1 variant devoid of the actin-binding domain (MKL1 ΔN200). We characterized the adaptive changes that occur during the MKL1-induced cellular model and focused on regulation of translation machinery and metabolic adaptation. We performed a genome-wide analysis at the transcriptional and translational level using ribosome profiling complemented with RNA-Seq and analyzed the expression of components of the translation machinery and enzymes involved in energy metabolism. NGS data were correlated with metabolomic measurements and quantification of specific mRNAs extracted from polysomes and western blots. Our results reveal the expression profiles of a luminal to basal-like state in accordance with an epithelial to mesenchymal transition. During the transition, the synthesis of ribosomal proteins and that of many translational factors was upregulated. This overexpression of the translational machinery appears to be regulated at the translational level. Our results indicate an increase of ribosome biogenesis and translation activity. We detected an extensive metabolic rewiring occurring in an already "Warburg-like" context, in which enzyme isoform switches and metabolic shunts indicate a crucial role of HIF-1α along with other master regulatory factors. Furthermore, we detected a decrease in the expression of enzymes involved in ribonucleotide synthesis from the pentose phosphate pathway. During this transition, cells increase in size, downregulate genes associated with proliferation, and strongly upregulate expression of cytoskeletal and extracellular matrix genes. Our study reveals multiple regulatory events associated with metabolic and translational machinery adaptation during an epithelial mesenchymal-like transition process. During this major cellular transition, cells achieve a new homeostatic state ensuring their survival. This work shows that ribosome profiling complemented with RNA-Seq is a powerful approach to unveil in-depth global adaptive cellular responses and the interconnection among regulatory circuits, which will be helpful for identification of new therapeutic targets.